Sources Notice of Opportunity for Hearing (NOOH): Manookian, Edward. U.S
Why Compounded Tirzepatide is Powerful for PCOS Dual GIP/GLP-1 action addresses the metabolic dysfunction at the heart of PCOS with superior results
If you experience any side effects at all, it will likely be some increase in appetite and hunger, temporarily
The decision to use tirzepatide in MS patients should be based on: Presence of appropriate indications (type 2 diabetes or obesity with BMI 30 kg/m or 27 kg/m with weight-related comorbidity) Absence of contraindications Patient-specific factors including MS disease activity, functional status, and treatment goals Coordination between neurology and primary care/endocrinology teams Future research priorities should include prospective observational studies examining metabolic medication safety and efficacy in MS cohorts, as well as exploratory studies investigating whether weight loss and metabolic optimization influence MS disease trajectories
Authorship All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published
Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA